A development research study highlights a technique for early Alzheimers detection and prospective treatment by targeting a particular immune cell receptor, paving the way for more reliable interventions before the start of full-blown dementia.Researchers at Aarhus University have actually found an approach to identify Alzheimers disease before it progresses to dementia, possibly opening up new opportunities for treatment.A groundbreaking study might pave the method for early detection and potentially provide a path to decelerate the improvement of Alzheimers disease.Researchers have found a special receptor on immune cells that can efficiently bind and reduce the effects of harmful “beta proteins”, which are highly associated with the disease.”If we can trigger the bodys own immune system at an earlier stage of the illness, it might be possible to slow down its development before it develops into full-blown dementia,” he adds.A great leap for diagnosticsThe research study suggests that the activity of the peripheral immune system may play a crucial role in the bodys defense against Alzheimers by preventing the build-up of harmful proteins in the brain.The brand-new approach utilizes an advanced type of blood test analysis that is particularly delicate to the early phases of the disease. What will an early diagnosis of Alzheimers mean for clients and their families when there is currently no efficient treatment for the disease?